News & Analysis as of

Healthcare Due Diligence

Sheppard Mullin Richter & Hampton LLP

Update: OHCA Approves Amendments to Cost and Market Impact Review (CMIR) Regulations

California’s Office of Health Care Affordability (OHCA) has officially approved amendments (“Amendments”) to the cost and market impact review (CMIR) regulations, effective August 22, 2024. Most significantly, these...more

Husch Blackwell LLP

Healthcare Founders Face New Exit Considerations

Husch Blackwell LLP on

Exiting a business, whether you are a serial entrepreneur looking to move on to the next project or a healthcare provider like a physician or therapist who has nurtured your practice for decades, can be difficult. After all,...more

Troutman Pepper

Checking the Pulse: An Approach to Telehealth Privacy and Cybersecurity Due Diligence

Troutman Pepper on

In the rapidly evolving landscape of health care, the surge in telehealth has been nothing short of revolutionary. This digital transformation, while offering unprecedented access to health care services, also introduces a...more

Health Care Compliance Association (HCCA)

The compliance lessons in the wake of the Supreme Court decision in U.S. ex rel Schutte v. SuperValu, Inc.

The False Claims Act (FCA) permits private individuals to bring lawsuits in the name of the United States—called qui tam—against those they believe have defrauded the federal government: 31 U.S.C. § 3730(b). The FCA thereby...more

HaystackID

The Pulse of M&A Activity: January 2024 HSR Transactions and Economic Analysis

HaystackID on

Editor’s Note: The Hart Scott Rodino Act (HSR Act), a pivotal federal law, mandates companies to notify the Federal Trade Commission (FTC) and the Department of Justice (DOJ) before finalizing mergers or acquisitions...more

Foley & Lardner LLP

Episode 29: Let’s Talk Compliance: How Compliance Issues Affect Health Care Transactions

Foley & Lardner LLP on

In this episode, partner Jana Kolarik of Foley’s Health Care Practice Group interviews partner Roger Strode of Foley’s Health Care and Transactional Practice Groups and Michael Ramey, managing principal of PYA's Strategic and...more

Butler Snow LLP

Health Care Due Diligence: An Ounce of Prevention is Worth a Pound of Cure

Butler Snow LLP on

Due diligence properly performed in connection with the purchase and sale of a health care entity is simply different—vastly so—than due diligence performed in other contexts. Failure to recognize this reality can lead to...more

Epstein Becker & Green

How Sellers Should Prepare for Transactional Diligence

Epstein Becker & Green on

Due diligence is a standard phase of any corporate transaction, whether structured as an asset or stock sale or joint venture, and sellers are often surprised, and even overwhelmed, by the comprehensiveness of the diligence...more

Gardner Law

Healthcare Enforcement in a Post-Pandemic World

Gardner Law on

After a year-over-year reduction in drug, device, and biologic Warning Letters from 2012 through 2019, Warning Letters spiked to pre-2014 levels in 2020 during the pandemic. This was due in large part to a significant number...more

Foley & Lardner LLP

Growing Scrutiny of Private Equity in Health Care

Foley & Lardner LLP on

The presence of private equity (PE) investment has exploded in recent years in all areas of the health care sector. PE in health care is a good thing when done right: It can pave the way for much needed innovation,...more

McDermott Will & Emery

HPE Miami 2023 | Buyer Beware: The Importance of Due Diligence in Healthcare Transactions

McDermott Will & Emery on

In this session, McDermott partners Matt Friendly and Ann Marie Brodarick moderated a panel discussion highlighting current considerations for buyers conducting legal and financial due diligence in healthcare M&A....more

McDermott Will & Emery

HPE Miami 2023 | Preparing Your Company for a Transaction

McDermott Will & Emery on

The first session of HPE Miami 2023 put a spotlight on key considerations for founders as they navigate the pre-transaction process...more

Mintz - Health Care Viewpoints

Health Care Deal Structures: What Will the Deal Look Like?

Deal structure is the foundation of a health care transaction. This post offers practical tips and hypothetical case studies for laying the groundwork for a successful health care transaction....more

Pillsbury Winthrop Shaw Pittman LLP

Acquiring a Distressed Business in the United States: Key Issues for Prospective Buyers

Prospective buyers should prepare to take advantage of opportunities to acquire distressed businesses, as we are likely to see an uptick in distressed M&A soon. Prospective buyers seeking first-mover advantages should act...more

Husch Blackwell LLP

ESG Due Diligence Considerations in the Healthcare Industry

Husch Blackwell LLP on

Environmental, Social and Governance (ESG) strategy is an increasingly more common consideration for those undertaking healthcare M&A or capital investments. The nature of healthcare poses unique ESG risks in terms of...more

Troutman Pepper

Limiting PE Firms’ Exposure to FCA Liability for Alleged Misconduct by Portfolio Companies

Troutman Pepper on

There are many concerns that can keep private equity (PE) firms’ management teams up at night. Economic headwinds, geopolitical instability, and supply chain problems can change the fortunes of a PE firm and its portfolio...more

White & Case LLP

Global private equity delivers groundbreaking 2021

White & Case LLP on

In line with overall M&A trends, global private equity had a blockbuster 2021 by any metric, but perhaps the best is this: In a record-setting year for global M&A, a record was also set for the percentage of M&A deals that...more

Pullman & Comley, LLC

Due Diligence in Home Health M&A Transactions

Pullman & Comley, LLC on

In the first article in our series discussing home health M&A transactions, we discussed the various structures that may be used to combine home health agencies (HHAs) with each other or with other entities. Whichever...more

PilieroMazza PLLC

8 Tips to Manage Risks in Healthcare Transactions

PilieroMazza PLLC on

In a typical investment or acquisition, the buyer conducts due diligence of the target company. Due diligence involves extensive review of the target company’s history, finances, and operations, including its contracts,...more

Epstein Becker & Green

[Webinar] Beyond the First Partnership – Second Bites and More: Part 2 of Physician Group Transactions 2020 – Prospering in Health...

Epstein Becker & Green on

This three-part webinar series will guide leaders of independent medical groups through the process of exploring various options in order to strategically position themselves for long-term success. Learn about Part 1 (April...more

Epstein Becker & Green

[Webinar] Physician Transactions 2020 – What’s Going On, and What Do You Need to Know? Part 1 of Physician Group Transactions 2020...

Transaction activity across the health care industry steadily increased throughout 2019. This activity is expected to continue through 2020 and into 2021, but it may experience a slowdown for a few months due to the...more

McGuireWoods LLP

Healthcare Regulatory Diligence: “What Does it Mean to Financial Underwriting?”

McGuireWoods LLP on

It’s deal time! The 2016 JP Morgan Healthcare Conference has set the tone for another successful year for healthcare investing. A company’s financial health is a key factor in the underwriting process for any type of loan...more

Perkins Coie

M&A Transactions: Affordable Care Act Due Diligence Considerations

Perkins Coie on

The Affordable Care Act (ACA) has significantly changed the legal landscape for employer-sponsored health plans by adding reporting obligations, benefit mandates, fees, notices and potential penalties for plans that do not...more

Womble Bond Dickinson

Is Your HIPAA Compliance Program Ready for the FTC?

Womble Bond Dickinson on

Everyone in healthcare knows that the next round of HIPAA audits is coming. Covered entities and business associates have long been advised to review and update their HIPAA security risk analyses, have business associate...more

Troutman Pepper

Some Useful Insights from Steris-Synergy Merger Case

Troutman Pepper on

The Federal Trade Commission suffered a rare loss when, on Sept. 24, the U.S. District Court for the Northern District of Ohio denied its request for a preliminary injunction, despite having accepted the FTC’s “actual...more

34 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide